Company news
China Meheco Group Co., Ltd. news in 2026
China Meheco Group Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600056)"China Meheco Group Co., Ltd."Full Text of Report for Q3 2026
October 29, 2026
(600056)"China Meheco Group Co., Ltd."Announcement on Convening the Q3 2026 Performance Briefing
October 29, 2026
Announcement on Progress of Litigation Involving the Company
September 8, 2026
Announcement on Appointment of Board Secretary
September 7, 2026
Announcement on Departure of the Board Secretary
September 1, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
August 25, 2026
Announcement on Completion of Redemption of the 1st Tranche of Super Short-term Commercial Papers for 2025
August 10, 2026
Announcement on Issuance Results of Super Short-term Commercial Paper for 2026
August 6, 2026
Announcement on the Proposed Selection of the Subsidiaries in the 12th Batch of National Centralized Drug Procurement
August 3, 2026
Announcement on Resolutions of the 5th Meeting of the 10th Board of Directors
July 28, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application
July 20, 2026
Announcement on the Subsidiary's Receipt of the Approval for Marketing of a Chemical API
July 16, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 17, 2026
Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
June 8, 2026
Announcement on Subsidiary Obtaining Notice of Approval for Drug Supplementary Application
May 29, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 20, 2026
Report for Q1 2026
April 28, 2026
Announcement on 2025 Annual Profit Distribution Plan
April 24, 2026
Announcement on Obtaining Drug Registration Certificate by Subsidiary
April 20, 2026
Announcement on Result of Public Issuance of Corporate Bonds (Phase I) to Professional Investors in 2026
April 17, 2026
Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
March 31, 2026
Announcement on Providing Guarantee for Holding Company
February 27, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
February 9, 2026
Announcement on Progress in Litigation Involved by the Company
February 5, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application
January 29, 2026
Notice on Convening the 1st Extraordinary General Meeting in 2026
January 23, 2026
Announcement on Reply to the Regulatory Work Letter Regarding Matters Related to Asset Acquisition
January 21, 2026
Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
January 16, 2026
Announcement on Obtaining Registration Approval for Public Issuance of Corporate Bonds to Professional Investors
January 12, 2026
Announcement Regarding the Subsidiary's Receipt of the "Tax Matters Notice" and Related Matters Concerning the Payment of Back Taxes
December 31, 2025